It has emerged that digital health company Biofourmis is in need of a new chief executive after co-founder Kuldeep Singh Rajput stepped down from the role.
Chugai has renewed and extended a partnership with Biofourmis, focusing on the use of a digital toolkit to assess and manage pain in people with endometriosis, designed to
One of the digital health sector's latest unicorn companies – Biofourmis – has upscaled its recent fourth round financing, adding $20 million to the $300 million it
Biofourmis has raised $300 million in fourth-round financing, sending its value rocketing to around $1.3 billion and injecting some fresh momentum into the digital health sector after a
A digital therapeutic for patients with heart failure has been awarded breakthrough device status by the FDA – said by its developer Biofourmis to be the first time the US regulator has gi
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio